Professor James Dale is a world-renowned plant biotechnologist with more than 25 years in the biotechnology research and development sector.
As the Chief Scientific Officer for the company, James is personally leading a team of plant biotechnologists and researchers to develop existing and new applications of Farmacule’s core INPACT technology.

His prior achievements include the invention of FNC/GeneCo Technology, which was sold in 2000 by the CRC for Diagnostic Techniques and the Queensland University of Technology in a multi-million dollar deal to the world’s leading gene chip company Affymetrix (NASDAQ: AFFX).

James has published in excess of 70 research papers and contributed to the invention of more than six patents. He has also served as a member of Australia’s Genetic Modification Advisory Council and, in 2001, helped draft national legislation to govern the genetic modification of organisms.

He is currently a member of the Gene Technology Technical Advisory Committee (GTTAC) in Australia.